These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 26722203)

  • 21. Management of functional neuroendocrine tumors of the pancreas.
    Öberg K
    Gland Surg; 2018 Feb; 7(1):20-27. PubMed ID: 29629316
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surgical resection of neuroendocrine tumors of the pancreas (pNETs) by minimally invasive surgery: the laparoscopic approach.
    Shirota T; Nagakawa Y; Sahara Y; Takishita C; Hijikata Y; Hosokawa Y; Nakajima T; Osakabe H; Katsumata K; Tsuchida A
    Gland Surg; 2018 Feb; 7(1):12-19. PubMed ID: 29629315
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inherited syndromes involving pancreatic neuroendocrine tumors.
    Geurts JL
    J Gastrointest Oncol; 2020 Jun; 11(3):559-566. PubMed ID: 32655935
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nonfunctional Pancreatic Neuroendocrine Tumors: Advances in Diagnosis, Management, and Controversies.
    Dumlu EG; Karakoç D; Özdemir A
    Int Surg; 2015 Jun; 100(6):1089-97. PubMed ID: 25590518
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuroendocrine tumors of the pancreas.
    Ehehalt F; Saeger HD; Schmidt CM; Grützmann R
    Oncologist; 2009 May; 14(5):456-67. PubMed ID: 19411317
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metachronous hormonal syndromes in patients with pancreatic neuroendocrine tumors: a case-series study.
    de Mestier L; Hentic O; Cros J; Walter T; Roquin G; Brixi H; Lombard-Bohas C; Hammel P; Diebold MD; Couvelard A; Ruszniewski P; Cadiot G
    Ann Intern Med; 2015 May; 162(10):682-9. PubMed ID: 25984844
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiangiogenic Therapy in Pancreatic Neuroendocrine Tumors.
    Capozzi M; VON Arx C; DE Divitiis C; Ottaiano A; Tatangelo F; Romano GM; Tafuto S;
    Anticancer Res; 2016 Oct; 36(10):5025-5030. PubMed ID: 27798861
    [TBL] [Abstract][Full Text] [Related]  

  • 28. May the robotic approach expand the indications for redo surgery in recurrent pNETs in Multiple Neuroendocrine Neoplasia type 1?
    Baz C; Dreifuss NH; Cubisino A; Schlottmann F; Mangano A; Aguiluz G; Vanetta C; Masrur MA; Giulianotti PC
    J Surg Case Rep; 2022 Sep; 2022(9):rjac433. PubMed ID: 36158249
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Updated Principles of Surgical Management of Pancreatic Neuroendocrine Tumours (pNETs): What Every Surgeon Needs to Know.
    de Ponthaud C; Menegaux F; Gaujoux S
    Cancers (Basel); 2021 Nov; 13(23):. PubMed ID: 34885079
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surgical Management of Pancreatic Neuroendocrine Tumors.
    Liu JB; Baker MS
    Surg Clin North Am; 2016 Dec; 96(6):1447-1468. PubMed ID: 27865287
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of Pancreatic Neuroendocrine Tumors: Surgical Strategies and Controversies.
    Perry RR; Feliberti EC; Hughes MS
    Endocr Pract; 2024 Jul; ():. PubMed ID: 39032831
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term outcomes in MEN-1 patients with pancreatic neuroendocrine neoplasms: an Israeli specialist center experience.
    Oleinikov K; Uri I; Jacob H; Epshtein J; Benson A; Ben-Haim S; Atlan K; Tal I; Meirovitz A; Maimon O; Lev-Cohain N; Mazeh H; Glaser B; Gross DJ; Grozinsky-Glasberg S
    Endocrine; 2020 Apr; 68(1):222-229. PubMed ID: 32036501
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cystic pancreatic neuroendocrine tumors: outcomes of preoperative endosonography-guided fine needle aspiration, and recurrence during long-term follow-up.
    Ridtitid W; Halawi H; DeWitt JM; Sherman S; LeBlanc J; McHenry L; Coté GA; Al-Haddad MA
    Endoscopy; 2015 Jul; 47(7):617-25. PubMed ID: 25763832
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Update on pancreatic neuroendocrine tumors.
    McKenna LR; Edil BH
    Gland Surg; 2014 Nov; 3(4):258-75. PubMed ID: 25493258
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-Term Outcomes of Tuberous Sclerosis Complex-Associated Non-functional Pancreatic Neuroendocrine Tumors: Should We Be More Conservative?
    Arya S; Ventin M; Nebbia M; Fernandez-Del Castillo C; Lionetto G; Qadan M; Lillemoe KD; Deshpande V; Catalano OA; Thiele EA; Ferrone CR
    Ann Surg Oncol; 2023 Nov; 30(12):7748-7755. PubMed ID: 37648887
    [TBL] [Abstract][Full Text] [Related]  

  • 36. B-mode and contrast-enhancement characteristics of small nonincidental neuroendocrine pancreatic tumors.
    Braden B; Jenssen C; D'Onofrio M; Hocke M; Will U; Möller K; Ignee A; Dong Y; Cui XW; Sãftoiu A; Dietrich CF
    Endosc Ultrasound; 2017; 6(1):49-54. PubMed ID: 28218201
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pancreatic neuroendocrine tumors: signal pathways and targeted therapies.
    Peng L; Schwarz RE
    Curr Mol Med; 2013 Mar; 13(3):333-9. PubMed ID: 23331005
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pancreatic Surgery.
    Maurizi A; Partelli S; Falconi M
    Front Horm Res; 2015; 44():139-48. PubMed ID: 26303709
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pancreatic neuroendocrine tumors: targeting the molecular basis of disease.
    Khagi S; Saif MW
    Curr Opin Oncol; 2015 Jan; 27(1):38-43. PubMed ID: 25390554
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sunitinib malate as first-line treatment for an advanced, poorly differentiated pancreatic neuroendocrine tumor.
    Lin LZ; Li P; Chen HR; Pang LJ
    Future Oncol; 2013 Jun; 9(6):909-13. PubMed ID: 23718311
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.